BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3007731)

  • 1. Antihypertensive aminotetralins related to labetalol and medroxalol.
    Clark RD; Caroon JM; Repke DB; Strosberg AM; Whiting RL; Brown CM
    J Pharm Sci; 1986 Jan; 75(1):80-2. PubMed ID: 3007731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and hypotensive properties of substituted 2-aminotetralins.
    Repke DB; Clark RD; Kluge AF; Muchowski JM; Strosberg AM; Lee CH; Whiting RL
    J Pharm Sci; 1985 Jan; 74(1):37-9. PubMed ID: 3981415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular properties of medroxalol, a new antihypertensive drug.
    Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1981; 3(2):299-315. PubMed ID: 6166802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Adrenergic agents. 2. Synthesis and alpha 1-agonist activity of 2-aminotetralins.
    DeMarinis RM; Shah DH; Hall RF; Hieble JP; Pendleton RG
    J Med Chem; 1982 Feb; 25(2):136-41. PubMed ID: 6120238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-phenol bioisosterism. Synthesis and antihypertensive activity of a pyrrolo analogue of labetalol.
    Asselin AA; Humber LG; Crosilla D; Oshiro G; Wojdan A; Grimes D; Heaslip RJ; Rimele TJ; Shaw CC
    J Med Chem; 1986 Jun; 29(6):1009-15. PubMed ID: 3012084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
    Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions.
    Cannon JG; Brubaker AN; Long JP; Flynn JR; Verimer T; Harnirattisai P; Costall B; Naylor RJ; Nohria V
    J Med Chem; 1981 Feb; 24(2):149-53. PubMed ID: 7205882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive 1-acyl-4-[2-(1,4-benzodioxan-2-yl)-2-hydroxyethylamino]pip eridines.
    Caroon JM; Clark RD; Repke DB; Kluge AF; Strosberg AM; Whiting RL; Okada MD; Hedley LR; Van Antwerp D; Brown CM
    J Pharm Sci; 1987 Jan; 76(1):32-4. PubMed ID: 3035169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 2. Derivatives of a hypotensive-positive inotropic agent.
    Stout DM; Gorczynski RJ
    J Med Chem; 1982 Mar; 25(3):326-8. PubMed ID: 7069709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminotetralins as narcotic antagonists. 2. Synthesis and opiate-related activity of 1-phenyl-3-aminotetralins.
    Fries DS; Bertelli DJ
    J Med Chem; 1982 Mar; 25(3):216-20. PubMed ID: 6121915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive effects of labetalol in three types of hypertensive models of rats (author's transl)].
    Nakagawa Y; Takeda K; Sakurai H; Mitomi A; Imai S
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):435-45. PubMed ID: 7286847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminotetralins as narcotic antagonists. Synthesis and opiate-related activity of 1-phenyl-2-aminotetralin derivatives.
    Reifenrath WG; Fries DS
    J Med Chem; 1979 Feb; 22(2):204-6. PubMed ID: 423201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
    Dausse JP; Guicheney P; Maich PJ; Meyer P
    Nouv Presse Med; 1978 Oct; 7(35):3121-3. PubMed ID: 31601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects.
    Atwal KS; O'Reilly BC; Ruby EP; Turk CF; Aberg G; Asaad MM; Bergey JL; Moreland S; Powell JR
    J Med Chem; 1987 Apr; 30(4):627-35. PubMed ID: 2435902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-Diamino-6,7-dimethoxyquinoline derivatives as alpha 1-adrenoceptor antagonists and antihypertensive agents.
    Campbell SF; Hardstone JD; Palmer MJ
    J Med Chem; 1988 May; 31(5):1031-5. PubMed ID: 2896245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
    Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
    J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.